08:00 , Dec 17, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: MicroRNA-130 (miR-130); miR-301

Cardiovascular disease INDICATION: Hypertension In vitro and rodent studies suggest inhibiting the miR-130/miR-301 family of miRNAs could help treat pulmonary arterial hypertension (PAH). miR-130a expression was higher in lungs from a rat model of PAH and human...
07:00 , Jul 31, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Hypertension MicroRNA-130 (miR-130); miR-301 Studies in human samples and mice suggest inhibiting miR-130- and miR-301-family miRNAs...